MSD’s Lipfendra takes on injectable rivals for cholesterol-lowering market supremacy
Filling a Keytruda-sized sales void was always going to be challenging, but Merck & Co (MSD) may have crafted a…
Filling a Keytruda-sized sales void was always going to be challenging, but Merck & Co (MSD) may have crafted a…